MariMed Inc. (CSE: MRMD)
MRMD trades on the Canadian Securities Exchange in Life Sciences. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of November 16, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for MRMD.CN, last bar 2026-11-13, computed by MarginsX. Website: sociallinks: 10-K text ("our website").
Profile
| Field | Value |
|---|---|
| Ticker | MRMD on the Canadian Securities Exchange |
| Yahoo symbol | MRMD.CN |
| Sector | Life Sciences, Drug Manufacturers—Specialty & Generic |
| Headquarters | The TMX list gives no head office |
| Listed | The TMX list gives no listing date |
| Listing type | TMX leaves listing type blank for long-listed issuers |
| Shares outstanding | 405,996,010 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | 0001522767 |
| Website | www.marimedinc.com |
Returns
| Window | Return |
|---|---|
| 1 day | -9.5% |
| 1 week | 0.0% |
| 1 month | +11.8% |
| 3 months | 0.0% |
| 6 months | -13.6% |
| Year to date | -20.8% |
| 1 year | -26.9% |
| From 52-week high | -48.6% |
| 52-week range | C$0.0650 to C$0.1850 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
27 documents in 7 types. Each title links to the document at its source.
News release (4)
| Document | Type | Filed |
|---|---|---|
| Press release, dated November 11, 2026, announcing financial results for the three- and nine-month periods ended September 30, 2026. Period 2026-09-30 | News release (8-K) | 2026-11-12 |
| MariMed Reports Third Quarter 2026 Earnings Period Q3 2026 | News release | 2026-11-11 |
| Press release, dated October 29, 2026. | News release (8-K) | 2026-10-29 |
| Press release, dated September 23, 2026. | News release (8-K) | 2026-09-23 |
Management information circular / proxy (1)
| Document | Type | Filed |
|---|---|---|
| DEF 14A | Proxy statement (DEF 14A) | 2026-09-22 |
Annual report (4)
| Document | Type | Filed |
|---|---|---|
| Form ARS: Annual report to security holders | Annual report to shareholders | No date |
| Form ARS: Annual Report to Security Holders | Annual report to shareholders | No date |
| Form ARS: Annual Report to Security Holders | Annual report to shareholders | No date |
| Form ARS: Annual report to security holders | Annual report to shareholders | No date |
Quarterly report (1)
| Document | Type | Filed |
|---|---|---|
| 10-Q Period 2026-09-30 | Quarterly report (10-Q) (10-Q) | 2026-11-13 |
Insider report (8)
| Document | Type | Filed |
|---|---|---|
| Form 4 | Form 4 (4) | 2026-11-09 |
| Form 4 | Form 4 (4) | 2026-10-15 |
| Form 4 | Form 4 (4) | 2026-10-15 |
| Form 4 | Form 4 (4) | 2026-10-15 |
Certification (4)
| Document | Type | Filed |
|---|---|---|
| EX-31.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
| EX-31.2 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
| EX-32.1 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
| EX-32.2 Period 2026-09-30 | Certification (SOX 302/906) (10-Q) | 2026-11-13 |
Other (5)
| Document | Type | Filed |
|---|---|---|
| 8-K | Current report (8-K) (8-K) | 2026-11-12 |
| 8-K | Current report (8-K) (8-K) | 2026-10-29 |
| 8-K | Current report (8-K) (8-K) | 2026-09-23 |
| MariMed Investor Presentation View Presentation | Investor presentation | No date |
Sources: SEC EDGAR filings (public records); Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Recent
| Date | Time | Event | Webcast | Source |
|---|---|---|---|---|
| 2026-11-12 | No time in the announcement | Q3 2026 earnings release | No webcast link announced | SEC filing |
| 2026-11-12 | 8:00 a.m. Eastern time | Q3 2026 earnings call | Webcast | SEC filing |
| 2026-10-28 | No time in the announcement | Special meeting Shareholder meeting | No webcast link announced | SEC filing |
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| MIR | MedMira Inc. | TSXV | C$37.9M | -42.9% | -42.9% |
| BCT | BriaCell Therapeutics Corp. | TSX | C$37.5M | -7.9% | -64.4% |
| SVA | Sernova Biotherapeutics Inc. | TSX | C$39.7M | 0.0% | -21.4% |
| LSL | LSL Pharma Group Inc. | TSXV | C$39.9M | +8.3% | -7.1% |
| PLTH | Planet 13 Holdings Inc. | CSE | C$40.2M | -20.0% | -50.0% |
The app has the price chart, every filing, private raises and the full peer set for MRMD.
Open in the app